Parsabiv Could Allow Amgen To Maintain Control Of Calcimimetics Market

 
• By Michael Cipriano
  
Lion
Amgen looks set to retain market dominance with Parsabiv • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip